NL300292I1 - Werkwijze voor het inhibiteren van botresorptie - Google Patents

Werkwijze voor het inhibiteren van botresorptie

Info

Publication number
NL300292I1
NL300292I1 NL300292C NL300292C NL300292I1 NL 300292 I1 NL300292 I1 NL 300292I1 NL 300292 C NL300292 C NL 300292C NL 300292 C NL300292 C NL 300292C NL 300292 I1 NL300292 I1 NL 300292I1
Authority
NL
Netherlands
Prior art keywords
bone resorption
disclosed
inhibiting bone
methods
etridronate
Prior art date
Application number
NL300292C
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451690&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300292(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9717590.5A external-priority patent/GB9717590D0/en
Priority claimed from GBGB9717850.3A external-priority patent/GB9717850D0/en
Application filed by Merck Sharp & Dohme Mfg filed Critical Merck Sharp & Dohme Mfg
Publication of NL300292I1 publication Critical patent/NL300292I1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL300292C 1997-07-22 2007-09-13 Werkwijze voor het inhibiteren van botresorptie NL300292I1 (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5335197P 1997-07-22 1997-07-22
US5353597P 1997-07-23 1997-07-23
GBGB9717590.5A GB9717590D0 (en) 1997-08-20 1997-08-20 Oral method for treating or preventing abnormal bone resorption
GBGB9717850.3A GB9717850D0 (en) 1997-08-22 1997-08-22 Oral method for treating or preventing abnormal bone resorption
EP98935752A EP0998292B1 (en) 1997-07-22 1998-07-17 Method for inhibiting bone resorption

Publications (1)

Publication Number Publication Date
NL300292I1 true NL300292I1 (nl) 2007-11-01

Family

ID=27451690

Family Applications (2)

Application Number Title Priority Date Filing Date
NL300223C NL300223I1 (nl) 1997-07-22 2006-02-07 Werkwijze voor het inhibiteren van botresorptie.
NL300292C NL300292I1 (nl) 1997-07-22 2007-09-13 Werkwijze voor het inhibiteren van botresorptie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL300223C NL300223I1 (nl) 1997-07-22 2006-02-07 Werkwijze voor het inhibiteren van botresorptie.

Country Status (31)

Country Link
EP (5) EP1175904B8 (nl)
JP (2) JP3479780B2 (nl)
KR (3) KR100391732B1 (nl)
CN (3) CN1299689C (nl)
AT (2) ATE209037T1 (nl)
AU (1) AU8493698A (nl)
BG (1) BG66282B1 (nl)
BR (1) BR9810779A (nl)
CA (1) CA2294595C (nl)
CY (2) CY1107535T1 (nl)
DE (6) DE69803291T2 (nl)
DK (2) DK1175904T3 (nl)
EA (1) EA004544B2 (nl)
EE (1) EE05603B1 (nl)
ES (3) ES2164447T3 (nl)
HK (5) HK1024166A1 (nl)
ID (1) ID24096A (nl)
IL (1) IL133535A0 (nl)
IS (3) IS5315A (nl)
LU (2) LU91222I2 (nl)
NL (2) NL300223I1 (nl)
NO (1) NO20000323L (nl)
NZ (1) NZ501807A (nl)
PL (1) PL195272B1 (nl)
PT (2) PT998292E (nl)
SG (2) SG109478A1 (nl)
SI (1) SI0998292T1 (nl)
SK (1) SK932000A3 (nl)
TR (1) TR200000145T2 (nl)
UY (1) UY25950A1 (nl)
WO (1) WO1999004773A2 (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1151793C (zh) 1998-12-25 2004-06-02 山之内制药株式会社 多发性骨髓瘤的骨病变治疗用医药组合物
ES2240106T3 (es) * 1999-05-21 2005-10-16 Novartis Ag Uso de acidos bisfosfonicos para el tratamiento de angiogenesis.
DE60043648D1 (de) * 1999-07-19 2010-02-25 Toray Industries Medikamente zur behandlung von periodontalen erkrankungen
WO2001046040A1 (en) 1999-12-20 2001-06-28 Merck & Co., Inc. Blister package for pharmaceutical treatment card
US20010044427A1 (en) * 1999-12-20 2001-11-22 Sidney Mazel Pharmaceutical kit
EP1267890A2 (en) * 2000-04-07 2003-01-02 The Board of Regents of The University of Texas System Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity
AU7410901A (en) 2000-06-20 2002-01-02 Novartis Ag Method of administering bisphosphonates
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
BR0209360A (pt) * 2001-05-02 2004-06-08 Novartis Ag Método de administração de bisfosfonatos por inalação no tratamento ou prevenção de reabsorção óssea e osteoporose
KR100642961B1 (ko) * 2002-05-10 2006-11-10 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
CA2539359A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
WO2005072747A1 (ja) * 2004-02-02 2005-08-11 Ono Pharmaceutical Co., Ltd. 骨吸収抑制剤
NZ567200A (en) * 2005-09-16 2010-08-27 Selamine Ltd Bisphosphonate formulation
CA2820019A1 (en) * 2010-12-06 2012-06-14 Effrx Pharmaceuticals Sa Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
CN106924257B (zh) * 2017-03-14 2019-11-19 湖南赛隆药业有限公司 质子泵抑制剂和抗骨质疏松药的复合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
ATE122228T1 (de) * 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.
ES2149781T3 (es) * 1991-11-22 2000-11-16 Procter & Gamble Pharma Composiciones de risedronato de liberacion retardada.
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
WO1994000129A1 (en) * 1992-06-30 1994-01-06 Procter & Gamble Pharmaceuticals, Inc. Use of phosphonates for the treatment of osteoporosis
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
AU703887B2 (en) * 1995-06-06 1999-04-01 Merck & Co., Inc. Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung

Also Published As

Publication number Publication date
EP1151752A2 (en) 2001-11-07
ID24096A (id) 2000-07-06
PL338635A1 (en) 2000-11-06
BR9810779A (pt) 2000-07-25
EP1151752A3 (en) 2002-12-18
KR100391732B1 (ko) 2003-07-16
PT1175904E (pt) 2007-04-30
HK1040494A1 (zh) 2002-06-14
WO1999004773A9 (en) 1999-10-28
CA2294595A1 (en) 1999-02-04
DE69803291T2 (de) 2002-08-08
NL300223I1 (nl) 2006-04-03
DK0998292T3 (da) 2002-05-13
EP1175904B8 (en) 2007-05-09
JP2005068010A (ja) 2005-03-17
KR20010022110A (ko) 2001-03-15
ES2269014T1 (es) 2007-04-01
CY2007022I1 (el) 2012-01-25
CN1602879A (zh) 2005-04-06
DK1175904T3 (da) 2007-05-07
HK1040495A1 (zh) 2002-06-14
EP1175904A2 (en) 2002-01-30
IS7230A (is) 2004-04-21
IS5315A (is) 1999-12-21
EA004544B2 (ru) 2006-12-29
CN1265035A (zh) 2000-08-30
EP1175903A3 (en) 2002-12-18
DE122007000063I1 (de) 2007-12-20
JP2002502433A (ja) 2002-01-22
EE200000040A (et) 2000-10-16
DE69803291D1 (de) 2002-02-21
CA2294595C (en) 2001-08-21
HK1042230A1 (zh) 2002-08-09
AU8493698A (en) 1999-02-16
LU91222I2 (fr) 2006-04-18
CY1107535T1 (el) 2012-01-25
DE69837450T2 (de) 2007-08-23
SK932000A3 (en) 2000-09-12
IL133535A0 (en) 2001-04-30
JP3479780B2 (ja) 2003-12-15
ATE357921T1 (de) 2007-04-15
IS7231A (is) 2004-04-21
ES2253136T1 (es) 2006-06-01
EP0998292B1 (en) 2001-11-21
NO20000323D0 (no) 2000-01-21
SG139556A1 (en) 2008-02-29
CN1602880A (zh) 2005-04-06
LU91364I2 (fr) 2007-11-12
HK1042232A1 (zh) 2002-08-09
EA004544B1 (ru) 2004-06-24
KR20030097611A (ko) 2003-12-31
UY25950A1 (es) 2000-09-29
EA200000151A1 (ru) 2000-10-30
DE69837450D1 (de) 2007-05-10
EP0998292A2 (en) 2000-05-10
EP1175904A3 (en) 2002-12-18
CN1299689C (zh) 2007-02-14
PL195272B1 (pl) 2007-08-31
EP1132088A2 (en) 2001-09-12
EP1175904B1 (en) 2007-03-28
SI0998292T1 (en) 2002-04-30
ATE209037T1 (de) 2001-12-15
KR20030097610A (ko) 2003-12-31
PT998292E (pt) 2002-04-29
TR200000145T2 (tr) 2000-05-22
ES2269014T3 (es) 2007-05-01
EE05603B1 (et) 2012-12-17
DE122006000009I1 (de) 2006-06-14
DE01201913T1 (de) 2007-02-08
WO1999004773A2 (en) 1999-02-04
EP1175903A2 (en) 2002-01-30
CN1166365C (zh) 2004-09-15
ES2164447T3 (es) 2002-02-16
CY2007022I2 (el) 2012-01-25
WO1999004773A3 (en) 1999-04-15
NZ501807A (en) 2003-02-28
HK1024166A1 (en) 2000-10-05
EP1132088A3 (en) 2002-04-24
DE01201911T1 (de) 2007-10-18
BG104093A (en) 2000-10-31
SG109478A1 (en) 2005-03-30
NO20000323L (no) 2000-03-20
BG66282B1 (bg) 2013-01-31

Similar Documents

Publication Publication Date Title
NL300292I1 (nl) Werkwijze voor het inhibiteren van botresorptie
NZ545804A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate
JP2005530819A5 (nl)
YU1800A (sh) Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju
PE120399A1 (es) Composiciones que inhiben la resorcion osea